Literature DB >> 19698780

Non-dopaminergic neurons partly expressing dopaminergic phenotype: distribution in the brain, development and functional significance.

M V Ugrumov1.   

Abstract

Besides the dopaminergic (DA-ergic) neurons possessing the whole set of enzymes of DA synthesis from l-tyrosine and the DA membrane transporter (DAT), the neurons partly expressing the DA-ergic phenotype have been first discovered two decades ago. Most of the neurons express individual enzymes of DA synthesis, tyrosine hydroxylase (TH) or aromatic l-amino acid decarboxylase (AADC) and lack the DAT. A list of the neurons partly expressing the DA-ergic phenotype is not restricted to so-called monoenzymatic neurons, e.g. it includes some neurons co-expressing both enzymes of DA synthesis but lacking the DAT. In contrast to true DA-ergic neurons, monoenzymatic neurons and bienzymatic non-dopaminergic neurons lack the vesicular monoamine transporter 2 (VMAT2) that raises a question about the mechanisms of storing and release of their final synthetic products. Monoenzymatic neurons are widely distributed all through the brain in adulthood being in some brain regions even more numerous than DA-ergic neurons. Individual enzymes of DA synthesis are expressed in these neurons continuously or transiently in norm or under certain physiological conditions. Monoenzymatic neurons, particularly those expressing TH, appear to be even more numerous and more widely distributed in the brain during ontogenesis than in adulthood. Most populations of monoenzymatic TH neurons decrease in number or even disappear by puberty. Functional significance of monoenzymatic neurons remained uncertain for a long time after their discovery. Nevertheless, it has been shown that most monoenzymatic TH neurons and AADC neurons are capable to produce l-3,4-dihydroxyphenylalanine (L-DOPA) from l-tyrosine and DA from L-DOPA, respectively. L-DOPA produced in monoenzymatic TH neurons is assumed to play a role of a neurotransmitter or neuromodulator acting on target neurons via catecholamine receptors. Moreover, according to our hypothesis L-DOPA released from monoenzymatic TH neurons is captured by monoenzymatic AADC neurons for DA synthesis. Such cooperative synthesis of DA is considered as a compensatory reaction under a failure of DA-ergic neurons, e.g. in neurodegenerative diseases like hyperprolactinemia and Parkinson's disease.Thus, a substantial number of the brain neurons express partly the DA-ergic phenotype, mostly individual complementary enzymes of DA synthesis, serving to produce DA in cooperation that is supposed to be a compensatory reaction under the failure of DA-ergic neurons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19698780     DOI: 10.1016/j.jchemneu.2009.08.004

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  40 in total

1.  Anatomical and electrophysiological changes in striatal TH interneurons after loss of the nigrostriatal dopaminergic pathway.

Authors:  Bengi Ünal; Fulva Shah; Janish Kothari; James M Tepper
Journal:  Brain Struct Funct       Date:  2013-10-31       Impact factor: 3.270

2.  Are striatal tyrosine hydroxylase interneurons dopaminergic?

Authors:  Harry S Xenias; Osvaldo Ibáñez-Sandoval; Tibor Koós; James M Tepper
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

3.  Dopamine is produced in the rat spinal cord and regulates micturition reflex after spinal cord injury.

Authors:  Shaoping Hou; David M Carson; Di Wu; Michelle C Klaw; John D Houlé; Veronica J Tom
Journal:  Exp Neurol       Date:  2015-12-02       Impact factor: 5.330

Review 4.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

5.  Synthesis of dopamine in non-dopaminergic neurons of the mediobasal hypothalamus of adult rats.

Authors:  V I Melnikova; Yu V Lyupina; A V Lavrentieva; A Ya Sapronova; M V Ugrumov
Journal:  Dokl Biol Sci       Date:  2012-11-06

6.  Tyrosine Hydroxylase Expression in Type II Cochlear Afferents in Mice.

Authors:  Pankhuri Vyas; Jingjing Sherry Wu; Amanda Zimmerman; Paul Fuchs; Elisabeth Glowatzki
Journal:  J Assoc Res Otolaryngol       Date:  2016-09-30

7.  Age-specific and context-specific responses of the medial extended amygdala in the developing prairie vole.

Authors:  Lisa C Hiura; Aubrey M Kelly; Alexander G Ophir
Journal:  Dev Neurobiol       Date:  2018-11-01       Impact factor: 3.964

8.  Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson's Disease.

Authors:  Gulnara R Khakimova; Elena A Kozina; Valerian G Kucheryanu; Michael V Ugrumov
Journal:  Mol Neurobiol       Date:  2016-05-19       Impact factor: 5.590

9.  Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate.

Authors:  Quentin Barraud; Ibrahim Obeid; Incarnation Aubert; Gregory Barrière; Hugues Contamin; Steve McGuire; Paula Ravenscroft; Gregory Porras; François Tison; Erwan Bezard; Imad Ghorayeb
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

10.  Tyrosine hydroxylase-producing neurons in the human cerebral cortex do not colocalize with calcium-binding proteins or the serotonin 3A receptor.

Authors:  Stephen E Asmus; Mary Ann Raghanti; Eric R Beyerle; Julia C Fleming-Beattie; Sarah M Hawkins; Courtney M McKernan; Nicholas A Rauh
Journal:  J Chem Neuroanat       Date:  2016-07-20       Impact factor: 3.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.